Tags

Type your tag names separated by a space and hit enter

American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Abstract

In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a complete update of recommendations for early prostate cancer detection. A series of systematic evidence reviews was conducted focusing on evidence related to the early detection of prostate cancer, test performance, harms of therapy for localized prostate cancer, and shared and informed decision making in prostate cancer screening. The results of the systematic reviews were evaluated by the ACS Prostate Cancer Advisory Committee, and deliberations about the evidence occurred at committee meetings and during conference calls. On the basis of the evidence and a consensus process, the Prostate Cancer Advisory Committee developed the guideline, and a writing committee drafted a guideline document that was circulated to the entire committee for review and revision. The document was then circulated to peer reviewers for feedback, and finally to the ACS Mission Outcomes Committee and the ACS Board of Directors for approval. The ACS recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested.

Links

  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    University of Virginia School of Medicine, Charlottesville, VA, USA.

    , , , , , , , , , , ,

    Source

    MeSH

    Antineoplastic Agents, Hormonal
    Anxiety
    Biopsy, Fine-Needle
    Continuity of Patient Care
    Decision Making
    Early Detection of Cancer
    Evidence-Based Medicine
    Humans
    Life Expectancy
    Male
    Mass Screening
    Phlebotomy
    Physical Examination
    Prostate
    Prostate-Specific Antigen
    Prostatectomy
    Prostatic Neoplasms
    Radiotherapy
    Randomized Controlled Trials as Topic
    Rectum
    Reference Values
    Risk Assessment
    Risk Factors
    SEER Program
    Sexual Dysfunction, Physiological
    United States
    Urinary Incontinence, Stress

    Pub Type(s)

    Journal Article
    Practice Guideline
    Review

    Language

    eng

    PubMed ID

    20200110

    Citation

    Wolf, Andrew M D., et al. "American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010." CA: a Cancer Journal for Clinicians, vol. 60, no. 2, 2010, pp. 70-98.
    Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70-98.
    Wolf, A. M., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., ... Smith, R. A. (2010). American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA: a Cancer Journal for Clinicians, 60(2), pp. 70-98. doi:10.3322/caac.20066.
    Wolf AM, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA Cancer J Clin. 2010;60(2):70-98. PubMed PMID: 20200110.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - American Cancer Society guideline for the early detection of prostate cancer: update 2010. AU - Wolf,Andrew M D, AU - Wender,Richard C, AU - Etzioni,Ruth B, AU - Thompson,Ian M, AU - D'Amico,Anthony V, AU - Volk,Robert J, AU - Brooks,Durado D, AU - Dash,Chiranjeev, AU - Guessous,Idris, AU - Andrews,Kimberly, AU - DeSantis,Carol, AU - Smith,Robert A, AU - ,, Y1 - 2010/03/03/ PY - 2010/3/5/entrez PY - 2010/3/5/pubmed PY - 2010/4/7/medline SP - 70 EP - 98 JF - CA: a cancer journal for clinicians JO - CA Cancer J Clin VL - 60 IS - 2 N2 - In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a complete update of recommendations for early prostate cancer detection. A series of systematic evidence reviews was conducted focusing on evidence related to the early detection of prostate cancer, test performance, harms of therapy for localized prostate cancer, and shared and informed decision making in prostate cancer screening. The results of the systematic reviews were evaluated by the ACS Prostate Cancer Advisory Committee, and deliberations about the evidence occurred at committee meetings and during conference calls. On the basis of the evidence and a consensus process, the Prostate Cancer Advisory Committee developed the guideline, and a writing committee drafted a guideline document that was circulated to the entire committee for review and revision. The document was then circulated to peer reviewers for feedback, and finally to the ACS Mission Outcomes Committee and the ACS Board of Directors for approval. The ACS recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested. SN - 1542-4863 UR - https://www.unboundmedicine.com/medline/citation/20200110/full_citation L2 - https://doi.org/10.3322/caac.20066 DB - PRIME DP - Unbound Medicine ER -